Le Lézard
Classified in: Health, Business
Subjects: ECO, MAT

Canopy Growth Congratulates Canopy Rivers (TSXV:RIV) for its Listing on the TSX Venture Exchange


SMITHS FALLS, ON, Sept. 20, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth") wishes to congratulate the entire team at Canopy Rivers Inc. as they take a leap forward and commence trading today on the TSX Venture Exchange as under the ticker symbol, "RIV".

Canopy Rivers was founded to diversify Canopy Growth's cannabis supply streams and quickly evolved into a global strategic growth platform that builds value in its partners by supporting every aspect of a cannabis venture, from licensing and genetics to financial and strategic support leveraging its close relationship with Canopy Growth.

To date, Canopy Rivers has a diverse portfolio of strategic investments including licensed cannabis producers, applicants, an innovative media platform, and a leading European hemp cultivator. This diverse portfolio will expand as new opportunities emerge in the global cannabis industry.

"Canopy Rivers presents a world of opportunity for its partners and for Canopy Growth. It's the type of relationship that allows us to continue to grow our lead in this incredibly dynamic industry, and we at Canopy Growth couldn't be more excited for Canopy Rivers to be taking this transformative step into the public markets," said Bruce Linton, Chairman and co-CEO, Canopy Growth and Acting CEO, Canopy Rivers. "Whether it's access to new brands, new technologies, differentiated products, first rights to future financing opportunities, and even rights to future full acquisition, Rivers will build value for shareholders, including Canopy Growth by building value for its portfolio partners."

Canopy Rivers' management team and Board of Directors bring decades of diverse collective experience in finance, regulated cannabis, retail, media, technology, and more. To learn more about Canopy Rivers and their mission, visit www.canopyrivers.com.

Here's to Future (Diversified) Growth.

Notice Regarding Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget" "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be" taken, "occur" or "be achieved". Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements with respect to the commencement of trading of the Subordinated Voting Shares, Canopy Growth's expectations in connection with the sale or purchase of additional securities of Canopy Rivers in the future, on the open market or in private transactions. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Although Canopy Growth believes the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

 

SOURCE Canopy Growth Corporation


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: